Study of Ibrutinib Combination Therapy in Selected Advanced Gastrointestinal and Genitourinary Tumors (PCYC-1128-CA)
Study of Ibrutinib Combination Therapy in Selected Advanced Gastrointestinal and Genitourinary Tumors (PCYC-1128-CA)
Trial Category:
Genitourinary
Phase
I
Contact(s)
Location(s)
Methodist Estabrook Cancer Center, Omaha, NE
